BSE Live
Jan 15, 15:59Prev. Close
3.97
Open Price
4.06
Bid Price (Qty.)
4.11 (2390)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 11, 15:18Prev. Close
4.15
Open Price
4.40
Bid Price (Qty.)
4.20 (500)
Offer Price (Qty.)
4.25 (2249)
| Profit & Loss account of Jupiter Bioscience (in Rs. Cr.) | Mar 06 | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||
| Revenue From Operations [Gross] | 80.02 | 70.98 | 65.73 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 80.02 | 70.98 | 65.73 | |
| Total Operating Revenues | 80.02 | 70.98 | 65.73 | |
| Other Income | 0.16 | 0.11 | 0.15 | |
| Total Revenue | 80.18 | 71.09 | 65.88 | |
| EXPENSES | ||||
| Cost Of Materials Consumed | 44.82 | 47.11 | 45.09 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.31 | 0.26 | 0.17 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -1.36 | -2.79 | -1.60 | |
| Employee Benefit Expenses | 2.16 | 1.87 | 2.74 | |
| Finance Costs | 4.16 | 3.14 | 3.05 | |
| Depreciation And Amortisation Expenses | 9.20 | 7.56 | 6.06 | |
| Other Expenses | -3.96 | -7.98 | -8.58 | |
| Total Expenses | 58.26 | 51.09 | 47.83 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 21.92 | 20.01 | 18.05 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 21.92 | 20.01 | 18.05 | |
| Tax Expenses-Continued Operations | ||||
| Current Tax | 5.29 | 3.09 | 2.22 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -0.55 | 0.57 | 0.03 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 4.79 | 3.66 | 2.25 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 17.14 | 16.35 | 15.80 | |
| Profit/Loss From Continuing Operations | 17.14 | 14.16 | 15.23 | |
| Profit/Loss For The Period | 17.14 | 14.16 | 15.23 | |
| OTHER ADDITIONAL INFORMATION | ||||
| EARNINGS PER SHARE | ||||
| Basic EPS (Rs.) | 19.34 | 15.98 | 17.18 | |
| Diluted EPS (Rs.) | 19.34 | 15.98 | 17.18 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 39.10 | 38.63 | 36.43 | |
| STORES, SPARES AND LOOSE TOOLS | ||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||
| Equity Share Dividend | 2.22 | 1.99 | 1.77 | |
| Tax On Dividend | 0.31 | 0.28 | 0.23 | |
| Equity Dividend Rate (%) | 25.00 | 23.00 | 20.00 |
23.03.2026
Alkem Laboratories gets DCGI nod for Semaglutide Injection; share price fall marginally
23.03.2026
22.03.2026
Sell-on-rise market? SBI Securities sees Nifty under pressure, picks two stocks for the week ahead
20.03.2026
Eris Lifesciences, Natco Pharma to launch generic Ozempic at 90% cheaper price
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth